Frontlight ResearchEarly access
Alzheimer disease trials in Singapore
5 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study of LY3439539 in Participants With Alzheimer's Disease
- Where
- Singapore
- Age
- 50 years to 85 years
- People
- 30 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07598370 - Phase 2Taking peopleA Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Where
- Singapore
- Age
- 50 years to 85 years
- People
- 340 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07033494 · EU 2024-519190-19-00 - Phase 3Not yet taking people in SingaporeAlzheimer's Disease THErapy With NEuroaid II
- Where
- Singapore
- Age
- 50 years and over
- People
- 350
- Run by
- Moleac Pte Ltd.
See details and how to joinNCT07191028 - No phaseNot yet taking people in SingaporeA Study to Compare Two Different Sleep Tests in Participants With No Symptoms or Early Symptoms of Alzheimer's Disease
- Where
- Singapore
- Age
- 55 years to 85 years
- People
- 35
- Run by
- Eli Lilly and Company
See details and how to joinNCT07485153 - No phaseTaking peopleCervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)
- Where
- Singapore
- Age
- 50 years to 80 years
- People
- 10
- Run by
- Vincent Tay Khwee Soon
See details and how to joinNCT06965062